As expenditure on health care has increasingly become an area of public debate and concern, public and private health care decision-makers have called for more rigorous use of cost-benefit and cost-effectiveness analysis to guide spending. Concerns have arisen, however, about the overall quality of such analyses. This book discusses and evaluates best-practice methods of conducting cost-benefit and cost-effectiveness studies of pharmaceuticals and other medical technologies. It encompasses a wide variety of topics, ranging from measuring cost and effectiveness to discounting to the use of dynamic modelling of cost-effectiveness. The book also includes conceptual and practical aspects of cost-effectiveness analysis by researchers who have conducted applied research in these areas. Rarely does the book provide a singular solution to a measurement problem; rather, the reader is directed to choices among alternative approaches and an analysis of the advantages and disadvantages of each.

This book is about the cost effectiveness of present and future medical technologies.
Reviews
'A fine set of papers by superb authors who well describe the current state-of-the-art in cost benefit and cost effectiveness analysis.' Joseph P. Newhouse, Harvard University



Book Information
ISBN 9780521576468
Author Frank A. Sloan
Format Paperback
Page Count 288
Imprint Cambridge University Press
Publisher Cambridge University Press
Weight(grams) 383g
Dimensions(mm) 228mm * 153mm * 20mm